Name of applicant: |
Hikma Pharmaceuticals PLC |
Name of scheme: |
Hikma Pharmaceuticals PLC 2004 Stock Option Plan ("SOP") & Hikma Pharmaceuticals PLC 2005 Long-Term Incentive Plan ("LTIP") & Hikma Pharmaceuticals PLC 2009 Management Incentive Plan ("MIP") & Hikma Pharmaceuticals PLC 2014 Executive Incentive Plan ("EIP") |
Period of return |
From: |
1 October 2017 |
To: |
31 March 2018 |
Balance of unallotted securities under scheme(s) from previous return: |
SOP: 792,700 ordinary shares of 10 pence LTIP: 125,277 ordinary shares of 10 pence MIP: 187,461 ordinary shares of 10 pence EIP: 80,044 ordinary shares of 10 pence |
Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for): |
SOP: 0 ordinary shares of 10 pence LTIP: 0 ordinary shares of 10 pence MIP: 800,000 ordinary shares of 10 pence EIP: 1,200,000 ordinary shares of 10 pence |
Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G): |
SOP: 0 ordinary shares of 10 pence LTIP: 18,216 ordinary shares of 10 pence MIP: 9,345 ordinary shares of 10 pence EIP: 187,802 ordinary shares of 10 pence |
Equals: Balance under scheme(s) not yet issued/allotted at end of period: |
SOP: 792,700 ordinary shares of 10 pence LTIP: 107,061 ordinary shares of 10 pence MIP: 978,116 ordinary shares of 10 pence EIP: 1,092,242 ordinary shares of 10 pence |
|
|
|
|
|
